Analyst Price Targets — THC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 17, 2026 2:54 pm | — | Truist Financial | $270.00 | $232.06 | TheFly | Tenet Healthcare price target raised to $270 from $240 at Truist |
| February 16, 2026 12:40 pm | Stephen Baxter | Wells Fargo | $265.00 | $231.10 | TheFly | Tenet Healthcare price target raised to $265 from $229 at Wells Fargo |
| February 13, 2026 11:48 am | — | Guggenheim | $271.00 | $232.26 | TheFly | Tenet Healthcare price target raised to $271 from $257 at Guggenheim |
| February 13, 2026 11:19 am | Andrew Mok | Barclays | $257.00 | $232.26 | TheFly | Tenet Healthcare price target raised to $257 from $240 at Barclays |
| February 12, 2026 2:42 pm | — | UBS | $288.00 | $233.50 | TheFly | Tenet Healthcare price target raised to $288 from $260 at UBS |
| February 12, 2026 1:15 pm | — | Morgan Stanley | $260.00 | $228.75 | TheFly | Tenet Healthcare price target raised to $260 from $247 at Morgan Stanley |
| February 12, 2026 12:55 pm | — | RBC Capital | $277.00 | $226.35 | TheFly | Tenet Healthcare price target raised to $277 from $253 at RBC Capital |
| February 12, 2026 12:31 pm | Matthew Gillmor | KeyBanc | $250.00 | $226.35 | TheFly | Tenet Healthcare price target raised to $250 from $225 at KeyBanc |
| February 3, 2026 2:18 pm | Ben Hendrix | RBC Capital | $253.00 | $194.98 | TheFly | Tenet Healthcare price target raised to $253 from $252 at RBC Capital |
| January 7, 2026 11:27 am | — | Wells Fargo | $229.00 | $208.24 | TheFly | Tenet Healthcare price target lowered to $229 from $252 at Wells Fargo |
Latest News for THC
Amitell Capital Pte Ltd reduced its stake in shares of Tenet Healthcare Corporation (NYSE: THC) by 16.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,592 shares of the company's stock after selling 8,550 shares during the quarter.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fox Run Management L.L.C. boosted its holdings in shares of Tenet Healthcare Corporation (NYSE: THC) by 538.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,634 shares of the company's stock after acquiring an additional 7,282 shares
Citigroup Inc. trimmed its holdings in shares of Tenet Healthcare Corporation (NYSE: THC) by 7.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 369,555 shares of the company's stock after selling 29,416 shares during the quarter. Citigroup Inc.
Tenet (THC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for THC.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.